Harbour Investments, Inc. Cellectis S.A. Transaction History
Harbour Investments, Inc.
- $3.59 Billion
- Q2 2025
A detailed history of Harbour Investments, Inc. transactions in Cellectis S.A. stock. As of the latest transaction made, Harbour Investments, Inc. holds 4,500 shares of CLLS stock, worth $15,030. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,500
Previous 4,500
-0.0%
Holding current value
$15,030
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CLLS
# of Institutions
27Shares Held
13.2MCall Options Held
0Put Options Held
0-
Long Focus Capital Management, LLC San Juan, PR4.72MShares$15.8 Million0.33% of portfolio
-
B Group, Inc. Dallas, TX3.26MShares$10.9 Million3.82% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL3.18MShares$10.6 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V81.44MShares$4.8 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C3227KShares$757,7620.0% of portfolio
About Cellectis S.A.
- Ticker CLLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,510,800
- Market Cap $152M
- Description
- Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...